SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Operating Cash Flow
Cash generated by the company's core business operations during the period.
SANUWAVE Health, Inc.NASDAQ: SNWV
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow turns positive
Q1 FY2026 operating cash flow was $397K, compared with -$1.52M a year earlier. Trailing-twelve-month operating cash flow was $5.79M.
Context
- Operating cash flow amounted to 8.8% of revenue in FY2025, up 1.3 pp from a year earlier.
- Operating cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly operating cash flow holds near $397K or moves back toward the trailing-twelve-month quarterly average of $1.45M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 3.88M USD
- Year-over-year change
- +57.9%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.88M | +57.9% |
| FY2024 | 2024-12-31 | 2.46M | +154.1% |
| FY2023 | 2023-12-31 | (4.54M) | +73.6% |
| FY2022 | 2022-12-31 | (17.17M) | -167.9% |
| FY2021 | 2021-12-31 | (6.41M) | — |
Operating Cash Flow vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 operating cash flow of $5.79M is the 10th largest of the 11 companies compared; the peer median is $38.34M.
- Its year-over-year change of +3674.1% is the highest of 11, against a peer median of -1.7%.
- Operating cash flow amounts to 13.1% of revenue for SNWV, versus a peer median of 56.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $87.4M | -8.0% | — | 309.7% | |
| LTM Mar 2026 | $81.46M | +182.0% | +17.0% | 56.2% | |
| LTM Mar 2026 | $75.07M | +33.4% | -3.7% | 184.4% | |
| LTM Mar 2026 | $49.7M | -7.3% | +0.9% | — | |
| LTM Dec 2025 | $43.17M | +18.0% | -2.0% | 331.6% | |
| LTM Mar 2026 | $33.51M | -65.1% | -31.8% | 28.5% | |
| LTM Mar 2026 | $25.12M | +3.9% | -26.9% | 31.6% | |
| LTM Mar 2026 | $17.81M | +53.8% | +4.9% | 185.7% | |
| LTM Mar 2026 | $7.59M | -78.9% | +4.2% | 13.1% | |
| LTM Mar 2026 | $5.79M | +3674.1% | — | 13.1% | |
| LTM Mar 2026 | $1.11M | -81.9% | -33.1% | 0.3% | |
| Peer median (excluding SNWV) | $38.34M | -1.7% | -2.0% | 56.2% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| Deferred Income Tax | 28K | 2K | 4K | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 1.51M | 0 |
| Change in Working Capital | 9.93M | (1.12M) | (3.61M) | (2.9M) | (4.01M) |
| Accounts Receivables | (395K) | (1.75M) | (53K) | (486K) | (2.3M) |
| Inventory | 1.69M | (72K) | (2.8M) | (1.2M) | (2.28M) |
| Accounts Payables | 3.18M | (2.55M) | 1.55M | (1.42M) | (521K) |
| Other Working Capital | 5.46M | 3.25M | (2.3M) | 203K | 1.09M |
| Other Non-Cash Items | 9.66M | (6.71M) | 23.84M | 34.07M | (5.21M) |
| Operating Cash Flow | (6.41M) | (17.17M) | (4.54M) | 2.46M | 3.88M |
| Capital Expenditures | (529K) | 1.02M | 0 | (490K) | (1.94M) |
| Acquisitions (Net) | 0 | 332K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1.02M) | 21K | 0 | 5.38M |
| Investing Cash Flow | (529K) | 332K | 21K | (490K) | 3.43M |
| Debt Repayment | 3.38M | 16.59M | 5.85M | (2.46M) | (6.14M) |
| Common Stock Issued | 0 | 100K | 0 | 10.3M | 556K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.74M | 695K | (639K) | (1.49M) | 0 |
| Financing Cash Flow | 5.12M | 17.38M | 5.21M | 6.35M | (5.59M) |
| Effect of Forex Changes | (1K) | (13K) | (50K) | 121K | 0 |
| Net Change in Cash | (1.82M) | 534K | 644K | 8.44M | 1.72M |
| Free Cash Flow | (6.94M) | (16.15M) | (4.54M) | 1.97M | 1.93M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.